Nancy A. Grygiel - Nov 5, 2021 Form 4 Insider Report for AMGEN INC (AMGN)

Role
SVP & CCO
Signature
/s/ Nancy A. Grygiel
Stock symbol
AMGN
Transactions as of
Nov 5, 2021
Transactions value $
$0
Form type
4
Date filed
11/9/2021, 07:12 PM
Previous filing
May 12, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Award $0 +935 +7.41% $0.00 13.5 K Nov 5, 2021 Direct F1, F2, F3
holding AMGN Common Stock 92 Nov 5, 2021 401(k) Plan F4

Explanation of Responses:

Id Content
F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in two annual installments of 50% on 11/5/2022 and 11/5/2023, respectively.
F2 These shares include the following RSUs granted under the Company's equity plans: 153 RSUs which will vest on 4/27/2022; 452 RSUs which will vest in one installment on 5/3/2022 and one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; and 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3 These shares include 372 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4 These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.